• Analysis of Sociodemographic Determinants of Adverse Drug Events- Using the National Inpatient Sample Database

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Umeclidinium Bromide/Vilanterol 62.5/25 MCG Versus Tiotropium/Olodaterol 5/5 MCG in Symptomatic Patients with Chronic Obstructive Pulmonary Disease in Spain

    May 1, 2018, 00:00

  • Patient Reported Treatment Satisfaction With Palbociclib Combination Therapies For HR+/HER2– Advanced Or Metastatic Breast Cancer In Multiple Countries

    May 1, 2018, 00:00

  • The Economic Burden of Mechanically Ventilated Patients with Pneumonia in the US

    May 1, 2018, 00:00

  • Impact of Depression and Anxiety on the Quality of Life at the Population Level

    May 1, 2018, 00:00

  • Web-Based Computerized Adaptive Testing Via An Open-Source Platform

    May 1, 2018, 00:00

  • Locally Advanced Or Metastatic Urothelial Carcinoma In The United States- Economic Burden And Healthcare Utilization

    May 1, 2018, 00:00

  • Cost-Utility Analysis of Istent Trabecular Micro-Bypass Stent Versus Medications Only for Patients with Open-Angle Glaucoma in Colombia

    May 1, 2018, 00:00

  • Benchmarking HIV Quality Measures Across US Payer Types

    May 1, 2018, 00:00

  • Treatment Strategies in Children with Severe Sickle Cell Disease after the Introduction of L-Glutamine Powder- A Decision Analysis

    May 1, 2018, 00:00

  • Use of Multiple Concurrent Antipsychotics and Adverse Events Related to Antipsychotics in Children and Adolescents Enrolled in Mississippi Medicaid

    May 1, 2018, 00:00

  • A Study of Peripheral Lower-Extremity Diseases-Related Hospitalization Discharge Status and its Association with Diabetes Using a US National Database

    May 1, 2018, 00:00

  • Apixaban Compared With Low Molecular Weight Heparins For Prophylaxis In The Patients At Risk Of Venous Thromboembolism- A Systematic Review And Meta-Analysis

    May 1, 2018, 00:00

  • Comparison of Methods to Estimate Disease-Related Cost in the Truven Marketscan Adminstrative Claims Database

    May 1, 2018, 00:00

  • Designing and Implementing A New Model of Nutrition Care for Hospitalized Colombian Patients

    May 1, 2018, 00:00

  • Patient Reported Outcomes In Metastatic Renal Cell Carcinoma Patients Receiving Pazopanib In A Community Oncology Setting

    May 1, 2018, 00:00

  • Incorporating Homomorphically Encrypted Data in Studies of Real-World Evidence to Support Expanded Approvals of Cancer Treatments

    May 1, 2018, 00:00

  • National Health and Nutrition Examination Survey (NHANES) Analysis of the USA'S Obese Population and Related Comorbidities

    May 1, 2018, 00:00

  • Assessing the Potential Impact of Treating Hyperphagia Among People With Prader-Willi Syndrome Using Disease-Specific Qalys

    May 1, 2018, 00:00

  • Biopsy Procedures in Patients with Primary Lung Cancer

    May 1, 2018, 00:00

  • A Pilot Study on Cost Evaluation of Urgent Start Automated Peritoneal Dialysis and Hemodialysis in the Treatment of End-Stage Renal Disease in São Paulo, Brazil

    May 1, 2018, 00:00

  • Using Aggregate Data to Proxy Individual-Level Characteristics in Health Services Research- 9-Digit Zipcode Vs. CENSUS Block Group

    May 1, 2018, 00:00

  • Real-World Healthcare Costs Based On Medication Adherence, Risk Of Stroke And Bleeding In Patients Treated With Novel Anticoagulant Therapy

    May 1, 2018, 00:00

  • Therapy For Glioma- Indian Market Overview

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceftolozane/Tazobactam Plus Metronidazole as Empiric Therapy for the Treatment of Complicated Intra-Abdominal Infections in Colombia

    May 1, 2018, 00:00

  • Impact of Psychosocial Factors on Health Services Utilization and Cost of Care in Blood and Marrow Transplant Patients

    May 1, 2018, 00:00

  • Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada

    May 1, 2018, 00:00

  • Long-Term Cost-Effectiveness of Valbenazine and Deutetrabenazine For Tardive Dyskinesia

    May 1, 2018, 00:00

  • Potential Budget Impact Of High-Cost Therapies With Potential For Expanded Indications

    May 1, 2018, 00:00

  • Economic Value of Next Generation Sequencing Panels in Oncology - A Market Development Perspective

    May 1, 2018, 00:00

  • Sizing of the Migraine Population Treated with Preventive Medications for Migraine

    May 1, 2018, 00:00

  • Patient Goup Experiences of Engagement in Health Technology Appraisals for Rare Disease Treatments - A Pilot Study in the UK

    May 1, 2018, 00:00

  • Economic Evaluation of Ramucirumab as Second-Line Chemotherapy for Previously Treated Advanced Gastric or Gastro-Oesophageal Junction Adenocarcinoma in China

    May 1, 2018, 00:00

  • Descriptive Analysis of Commercially Insured Adult Opioid Users in The United States without Cancer or Hospi 2007-2015

    May 1, 2018, 00:00

  • Transporting the Results of A Clinical Trial to a New Target Population

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Endometriosis- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Emergency Room Visits and Out of Pocket Expenditure Among Individuals Enrolled in a High Deductible Health Plan

    May 1, 2018, 00:00

  • The Application of Electronic Medical Records (EMRS) as a Virtual Comparator Arm in a Lung Cancer Clinical Trial

    May 1, 2018, 00:00

  • Efficiency Test of Injury Prevention Program Among Junior Female Handball Players

    May 1, 2018, 00:00

  • A Measure of Health-Related Quality of Life (HRQOL) Associated with Chronic Conditions Using EQ-5D-5L in Hong Kong Sar,China

    May 1, 2018, 00:00

  • Analysis of Social Media Data Using Qualitative Methods- Understanding Preferences and Perceptions of Biologic Medications Among Patients with Severe Asthma

    May 1, 2018, 00:00

  • Assessing the Burden of Disease-Associated Malnutrition Among Hospitalized Malnourished Colombian Patients with Heart and Lung Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis Of Amisulpride And Olanzapine For Patients With Schizophrenia in China

    May 1, 2018, 00:00

  • Systematic Literature Review (SLR) Of Sequencing Of Anaplastic Lymphoma Kinase (ALK) Inhibitors In ALK-Positive Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Secukinumab Prescribing Patterns in Patients with Psoriatic Arthritis in the United States- Data from Secukinumab Service Request Forms

    May 1, 2018, 00:00

  • Economic Consequences of Clinically Important Deterioration in Patients with Chronic Obstructive Pulmonary Disease- Analysis of the Torch Study

    May 1, 2018, 00:00

  • Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada

    May 1, 2018, 00:00

  • The Feasibility of Utilizing Pharmacogenomics-Based Testing Techniques in the Treatment of HIV/AIDS- A Systematic Review

    May 1, 2018, 00:00

  • Development and Application of a Novel Patient-Reported Outcomes Instrument, The Psoriasis Symptoms and Signs Diary, Measuring Psoriasis Severity in Clinical Trials

    May 1, 2018, 00:00

  • Budget Impact Analysis of Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in Specialties Hospital In Ecuador

    May 1, 2018, 00:00

  • The Current Landscape and Future of Outcomes-Based Contracting with Commercial Healthcare Payers in the US

    May 1, 2018, 00:00

  • Comparing Rates and Reasons for Medication Non-Adherence Across Seventeen Disease Conditions, Three Modes of Administration, And two Frequencies of Administration, Using the Medication Adherence Reasons Scale (MAR-SCALE)

    May 1, 2018, 00:00

  • Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada

    May 1, 2018, 00:00

  • Healthcare Cost of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis

    May 1, 2018, 00:00

  • Baseline Health Utility Scores in Subjects with Suspected Ocular Disease- An Interim Analysis of the Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study

    May 1, 2018, 00:00

  • Bilateral Treatment in Patients with Neovascular Age-Related Macular Degeneration- A Retrospective Cohort Study in the US

    May 1, 2018, 00:00

  • Opioid Analgesic Prescribing Related to Dental Visits in the Mississippi Medicaid Population

    May 1, 2018, 00:00

  • Biosimilar Infliximab Utilization After Patent Expiry- The Case of Colitis Ulcerosa and Rheumatoid Arthritis in Hungary

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Anti-Diabetic Regimens in T2DM Patients Unexpectedly Maintain Their Hypoglycemic Regimens for a Long Duration- A Retrospective Clinical Data Analysis Study

    May 1, 2018, 00:00

  • Comparative Safety of Sleep Prescriptions and Suicide Attempts in Veterans

    May 1, 2018, 00:00

  • Combatting Rising Obesity in AMCP Dossiers? The New AMCP Dossier Format – Version 4.0

    May 1, 2018, 00:00

  • Identifying Adherence Barriers To Oral Endocrine Therapy (OET) Among Breast Cancer Patients

    May 1, 2018, 00:00

  • Quality Of Life Of Patients With Cancer Undergoing Chemotherapy In Belo Horizonte Hospitals

    May 1, 2018, 00:00

  • Incidence of Hepatocellular Carcinoma and Extrahepatic Cancers Among HCV-Infected Patients in the Era of Direct-Acting Antivirals

    May 1, 2018, 00:00

  • Taking The Burden Out Of Symptom Reporting In Patients With Melanoma Using A Digital Real-World Evidence Platform

    May 1, 2018, 00:00

  • Selective Serotonin Reuptake Inhibitors and Bone Mass Density

    May 1, 2018, 00:00

  • Opioid Overdose Risk Factors- A Matched Case Control Study in Mississippi Medicaid

    May 1, 2018, 00:00

  • Difficulty of Measuring Dose Response Due to Unreliability of Days Supply in Administrative Claims Data

    May 1, 2018, 00:00

  • Findings from the 2018 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Student Interest Survey

    May 1, 2018, 00:00

  • Day-To-Day Fluctuations in Older Adults' Cognitive Functioning- Moving Beyond Single Time Point Assessments

    May 1, 2018, 00:00

  • Patient Reported Outcomes in Psoriasis Treatment Decision Making- A Discrete Choice Experiment Survey of Dermatologists in the Us

    May 1, 2018, 00:00

  • Medication Usage, Length of Stay and Hospital Charges in Schizophrenia Patients- A Retrospective Analysis of a Large US Electronic Health Record Database

    May 1, 2018, 00:00

  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization in Patients with Diabetes

    May 1, 2018, 00:00

  • Assessing the Cost-Effectiveness of Three-Monthly Paliperidone Palmitate Versus its Prior Monthly Formulation for the Management of Schizophrenia in the UK Setting

    May 1, 2018, 00:00

  • Efficacy and Safety of Atosiban in Pregnant Women Under Threat of Preterm Labor- Systematic Review

    May 1, 2018, 00:00

  • How to Capture Authentic Patients' and Caregivers' Experience with Disease and Treatment- Establishing Trust with the "Gatekeepers" of Information

    May 1, 2018, 00:00

  • Replicating and Extending the Four-Factor Structure of the Medication Adherence Reasons Scale (MAR-SCALE) in Pain, Migraine, And Sleep Conditions Among People Using Daily and Weekly Administered Oral Medications

    May 1, 2018, 00:00

  • Role of Patient-Reported Outcome Evaluation in the Approval of Orphan Drugs- A Review of 15 Year Approvals by the FDA and the EMA

    May 1, 2018, 00:00

  • Economic Impact of Laparoscopic Vs Open Low Anterior Resection for Rectal Cancer Surgery- A Budget Impact Analysis

    May 1, 2018, 00:00

  • Factors Associated with Late Presentation for HIV Care Among Antiretroviral Therapy Clinic Registrants in Eastern Ghana- an Analytic Cross Sectional Study, 2013

    May 1, 2018, 00:00

  • Assessement of the Challenges Associated with Drug Innovation in Post-Traumatic Stress Disorder

    May 1, 2018, 00:00

  • Development of a Conceptual Model and Review of Patient-And Observer-Reported Outcome Measures in Atopic Dermatitis

    May 1, 2018, 00:00

  • Community Oncology Perceptions And Views On Genomic Testing In The Era Of Precision Oncology

    May 1, 2018, 00:00

  • Budgetary Impact and Cost Drivers of Drugs for Rare and Ultrarare Diseases

    May 1, 2018, 00:00

  • The Cost-Effectiveness of Treatments in Non-Cirrhotic Saudi Arabian Patients with Genotype 1 and Genotype 4 Chronic Hepatitis C

    May 1, 2018, 00:00

  • Healthcare Resource Utilization and Costs in Patients with Persistent Asthma by Attainment of Healthcare Effectiveness and Data Information Set (HEDIS) Measures

    May 1, 2018, 00:00

  • Medication Use Before and after Hospitalization for COPD in a Cohort of Elderly Patients with Medicare Advantage Plan

    May 1, 2018, 00:00

  • Dengue Vaccine Efficacy- A Systematic Review

    May 1, 2018, 00:00

  • Estimating the Lifetime Costs in Adult Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in the United States

    May 1, 2018, 00:00

  • Shared Decision Making and Satisfaction with Care Among Patients with Diabetes Mellitus

    May 1, 2018, 00:00

  • Salary Benchmarks and Compensation Disparity Among Global Health Economics and Market Access (HEORMA) Professionals Based on a 2017 Self-Report Survey

    May 1, 2018, 00:00

  • Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence

    May 1, 2018, 00:00

  • Cognitive Debriefing Interviews to Explore the Content Validity of the Chronic Liver Disease Questionnaire (CLDQ) and Eq-5D-5L in Patients with Chronic Hepatitis B

    May 1, 2018, 00:00

  • Differences in Antidepressant Medication Management Between Commercially Insured and Traditional Medicaid for Low Income Adults in Arkansas

    May 1, 2018, 00:00

  • Drug Use Among Seniors in Canada, 2016

    May 1, 2018, 00:00

  • Implications of Brexit on European Pharmaceutical Market Access

    May 1, 2018, 00:00

  • What are the Real Indirect Costs Associated with Multiple Myeloma- Model Patient Analysis From Slovak Republic

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Edoxaban Compared With Low Molecular Weight Heparin/Vitamin K Antagonist For The Treatment Of Venous Thromboembolism

    May 1, 2018, 00:00

  • The Benefits and Costs Of Different Scenarios for Varicella Vaccination in Chile

    May 1, 2018, 00:00

  • College Students' Beliefs About Prescription Drug Misuse Among Peers

    May 1, 2018, 00:00

  • Cost Per Responder Analysis of Guselkumab Versus Etanercept Using Efficacy Results from Pivotal Clinical Trials in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00

  • Calculating Appropriate ICERS in Diabetes Prevention Program (DPP) Cost-Effectiveness and Overturning Misleading Conclusions Regarding Optimal Treatment

    May 1, 2018, 00:00

  • Clinical And Economic Burden Of Distributive Shock In US Intensive Care Units In 2014

    May 1, 2018, 00:00

  • PRO2 Based Remote Monitoring in Ulcerative Colitis- A Prospective Real World Study

    May 1, 2018, 00:00

  • Estimating the Impact of Affordable Care Act (ACA) on Likelihood of Receiving Mammography and PAP Smear Screenings

    May 1, 2018, 00:00

  • Budget Impact for Olaparib Maintenance Therapy for Brca-Mutated Platinum Sensitive Recurrent Ovarian Cancer in Panama

    May 1, 2018, 00:00

  • Ablation Procedure Using Newer Radiofrequency Catheters (Thermocool® SF Catheter or Thermocool Smarttouch® Catheter) Versus Earlier Generation Thermocool® Catheter- A Real-World Comparison of Outcomes Using a us Hospital Database

    May 1, 2018, 00:00

  • Benefits of Adenotonsillectomy in Children with Mild Obstructive Sleep Apnea Syndrome

    May 1, 2018, 00:00

  • The Prevalence and Predictors of Concomitant use of Tyrosine Kinase Inhibitors and Proton Pump Inhibitors in Older Adults with Cancer- An Observational Study Using Seer-Medicare Data

    May 1, 2018, 00:00

  • Cancer Mortality Trends In Brazil And Mexico

    May 1, 2018, 00:00

  • Systematic Literature Review of Real-World Evidence on Persistence, Switching, and Dose Escalation with Biologics in Inflammatory Bowel Disease in the United States

    May 1, 2018, 00:00

  • Evaluation of Opioid use Among Patients with Back Disorders and Arthritis

    May 1, 2018, 00:00

  • Estimated Reduction in Medication Cost During first Year of a Continuous Care Intervention for Treatment of Type 2 Diabetes

    May 1, 2018, 00:00

  • Economic Burden of Diagnosed Chronic Migraine and Diagnosed Episodic Migraine Patients in a Large US Health Insurer’s Population

    May 1, 2018, 00:00

  • A Dynamic Approach for Budget Impact Analysis (BIA) in Oncology- Nonmetastatic Castration-Resistant Prostate Cancer (NMCRPC) as an Illustrative Example

    May 1, 2018, 00:00

  • Influence Factors and Economic Burden of Antidiabetics-Injection-Related Needle-Stick Injuries in China

    May 1, 2018, 00:00

  • Comparative Analysis of Total Medical Expenditure of Therapy with Nebulized Budesonide and Systemic Corticosteroids for Patients with COPD Exacerbation

    May 1, 2018, 00:00

  • Emergency Care in Marfan Syndrome- A Retrospective Hospital Analysis

    May 1, 2018, 00:00

  • Economic Burden of Cardiometabolic Disorders Among Patients with Asthma

    May 1, 2018, 00:00

  • A Mapping And Analysis Of National Accelerated Access Pathways For Cancer Drugs

    May 1, 2018, 00:00

  • Cost-Effectiveness of Edoxaban Compared with Dalteparin for the Treatment of Cancer-Associated Venous Thromboembolism

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of a First-in-Class, Triple Fixed Dose Combination Therapy Against Laba/Lama Therapy in Moderate-Severe COPD

    May 1, 2018, 00:00

  • Impact of Arkansas Medicaid Expansion Through Premium Purchase on the Utilization and Access to Prenatal Visits

    May 1, 2018, 00:00

  • A Review of the Costs of Lower Limb Amputations in Patients With Diabetes in the US

    May 1, 2018, 00:00

  • Setting the Boundaries for Economic Evaluation- Investigating Time Horizon and Family Effects in the Case of Postnatal Depression

    May 1, 2018, 00:00

  • Economic Consequences of Anti-HCV Antiviral Treatment Investment from the NHS Perspective

    May 1, 2018, 00:00

  • Positive Cancer Drug Recommendations By The Pan-Canadian Oncology Drug Review Are Not Without Conditions Placed On Cost-Effectiveness

    May 1, 2018, 00:00

  • An Algorithmic Approach To Optimal Study Design for Outcomes Research

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada

    May 1, 2018, 00:00

  • Cognitive and Mind-Body Therapies for the Treatment of Chronic Low Back Pain – A Cost-Effectiveness Analysis

    May 1, 2018, 00:00

  • Expanded Genomic Testing for Pediatric Cancers is Clinically Impactful But Reimbursement Lags Behind

    May 1, 2018, 00:00

  • Graphical Probabilistic Models for Risk Prediction and Decision Making Using Real-World Data- A Developing Tool for the Era of Precision Medicine

    May 1, 2018, 00:00

  • Examining the Effect of Missing Data on the Acmg Newborn Screening Criteria of Least Consensus for Carnitine Palmitoyltransferase II Deficiency (CPTII)

    May 1, 2018, 00:00

  • Comparing Short Form – 6 Dimension (SF-6D) Derived Utilities and Euroqol Questionnaire – 5 Dimensions (EQ-5D) Mapped Utilities Among Patients with Iron Deficiency in Inflammatory Bowel Disease (ID-IBD) Treated with Ferric Maltol (FM) Vs Pla ...

    May 1, 2018, 00:00

  • Assessment of the Use of Pharmacogenetics in the Diagnosis and Treatment of Schizophrenia- Results from a Survey of Psychiatrists

    May 1, 2018, 00:00

  • Economic Analysis of Abaloparatide in High-Risk Postmenopausal Women with Osteoporosis in the United States - A Discrete-Event Simulation Model

    May 1, 2018, 00:00

  • The Cost of Comorbid Depression Among Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • The Clinical Value of Early Diagnosis Tests for the Long-Term Management of Dementia

    May 1, 2018, 00:00

  • Use Of Biomarker Testing In Head And Neck Cancers In The United States And EU5

    May 1, 2018, 00:00

  • Utilization, Reimbursement, and Price of Incretin-Based and Peptides Therapies for Type 2 Diabetes in US Medicaid Program from 2005 to 2016

    May 1, 2018, 00:00

  • Incidence of Depression Following Traumatic Brain Injury

    May 1, 2018, 00:00

  • Calculating Rasch-Based Person Parameters for Individual Items

    May 1, 2018, 00:00

  • Drivers of Genomic Precision Medicine Adoption in the US- Payer Preferences

    May 1, 2018, 00:00

  • Synthetic Sample Generation Representing the English Population Using Spearman Rank Correlation and Chomsky Decomposition

    May 1, 2018, 00:00

  • Developing A Consolidated Checklist (Strwe-Retro) to Assess the Reporting Quality of Real World Evidence Studies Based on Retrospective Data Analyses

    May 1, 2018, 00:00

  • Challenges in Comparing Remission Outcomes in Network Meta-Analyses in Ulcerative Colitis

    May 1, 2018, 00:00

  • Cost-Effectiveness of Serial Cervical Length Screening to Prevent Preterm Birth Among High-Risk U.S. Women- A Decision Analysis

    May 1, 2018, 00:00

  • What is the Cost of a Breast Cancer Therapy Infusion? Real World Data on Brazilian Private Healthcare Perspective

    May 1, 2018, 00:00

  • The Association Between Anti-Epileptic Drug Adherence to Sodium Channel Blockers and Health-Related Quality of Life- Analysis of US Survey Data from Patients with Epilepsy

    May 1, 2018, 00:00

  • Assessing Cellulite Severity- Method for Assessing Reliability of a New Clinician-Reported and a New Patient-Reported Photonumeric Scale

    May 1, 2018, 00:00

  • Real-World Outcomes and Medication Adherence to Disease Modifying Therapies (DMTS) Among Patients with Multiple Sclerosis (MS)

    May 1, 2018, 00:00

  • Social Media Listening for Patient Risk Characterization

    May 1, 2018, 00:00

  • Determinants of Asthma in Children- Evidence from National Survey of Children’s Health in USA

    May 1, 2018, 00:00

  • Effectiveness of Guideline-Recommended Care Bundles- A Systematic Review

    May 1, 2018, 00:00

  • Extended-Duration VTE Prophylaxis With Orally Administered Betrixaban Saves Cost Compared To Standard-Duration Enoxaparin Across The Inpatient And Outpatient Settings

    May 1, 2018, 00:00

  • Insurance Marketplace Enrollment and In-Person Assistance Under the Affordable Care Act

    May 1, 2018, 00:00

  • The Association Between Prescription Stimulant Use and Prescription Drug Misuse

    May 1, 2018, 00:00

  • Budget Impact Analysis of Palbociclib for the Treatment of Patients With HR+/HER2− Advanced/Metastatic Breast Cancer In Bulgaria

    May 1, 2018, 00:00

  • Transplanting Kidneys from HCV Positive Donors into HCV Negative Recipients in the Era of Direct Acting Antiviral Therapy- A Cost Effectiveness Analysis

    May 1, 2018, 00:00

  • Variation In Locoregional Treatment Of Stage I – II Breast Cancer By Breast Subtype In Nonelderly Adult Women

    May 1, 2018, 00:00

  • Increased Healthcare Utilization in Dementia Subtypes Prior to Diagnosis

    May 1, 2018, 00:00

  • Perceptions of Biosimilars Across Physician Specialities in Europe

    May 1, 2018, 00:00

  • Ablation Versus Antiarrhythmic Drug Treatment Among Patients with Atrial Fibrillation- A Propensity-Matched Analysis

    May 1, 2018, 00:00

  • Cost-Minimization Analysis of Tafluprost/Timolol Maleate for Lowering Intraocular Pressure (IOP) in Adult Patients with Open-Angle Glaucoma or Ocular Hypertension in Bulgaria

    May 1, 2018, 00:00

  • Implementation of the South African Triaging Scale (SATS) System in Eastern Ghana- Assessment of Deployment at the Emergency Department of a Regional Hospital, 2015

    May 1, 2018, 00:00

  • Psychosocial and Other Non-Drug Treatments for Bipolar Disorder in Adults- A Systematic Review

    May 1, 2018, 00:00

  • Main Drivers of Direct Healthcare Costs for Osteoarthritis in The US- A Retrospective Private Insurance Claims Analysis Through 2014

    May 1, 2018, 00:00

  • Duration of Treatment and Economic Burden in Patients with Anaplastic Lymphoma Kinase Positive (ALK+) Non–Small Cell Lung Cancer (NSCLC) Receiving Second-Line Alk Inhibitors

    May 1, 2018, 00:00

  • A Retrospective Observational Study on Characteristics and Medical Resource Utilization of Long-Term Hospitalization Patients in China

    May 1, 2018, 00:00

  • Cost-Effectiveness of Donepezil in the Treatment of Patients With Alzheimer's Disease- An Update

    May 1, 2018, 00:00

  • Complications, Health Care Resource Utilization and Costs Associated with Type III Open Fractures of the Tibial Shaft Requiring Open Reduction and Internal Fixation

    May 1, 2018, 00:00

  • Treatment Patterns and Economic Burden of Chinese Metastatic Colorectal Cancer Patients- a Retrospective Study of Electronic Medical Records from Urban China

    May 1, 2018, 00:00

  • Optifast® Meal Replacement Program for the Treatment of Obesity- A Cost-Effectiveness Assessment from the Employer Perspective in the USA

    May 1, 2018, 00:00

  • Using Real-World Evidence for Health Technology Assessment Submissions- Lessons and Insights from Review Of Nice’s Technology Assessment Reports (2016-2017)

    May 1, 2018, 00:00

  • Do Commercial Health Care Prices Influence Medicare Spending?

    May 1, 2018, 00:00

  • The Impact of Ophthalmology in the Hungarian One-Day Surgery

    May 1, 2018, 00:00

  • Real World, Non-Interventional, Observational Study to Evaluate Effectiveness and Tolerability of Acotiamide Hydrochloride Hydrate in Indian Patients with Functional Dyspepsia

    May 1, 2018, 00:00

  • Approvals and Pricing of Factor VIII and Factor IX Concentrates for Hemophilia A and B in the United States

    May 1, 2018, 00:00

  • The Impact of Response at A Landmark on Overall Survival- Implications for the Economic Evaluation of the Value of Immuno-Oncology (I-O) Treatment in Non-Small Cell Lung Cancer (NSCLC)

    May 1, 2018, 00:00

  • Cost Effectiveness of Anti-PD-1/PD-L1 Treatments- Systematic Review of Published Studies

    May 1, 2018, 00:00

  • The Impact of Legislative Changes and Regulatory Guidance on Proactive Dissemination of Healthcare Economic Information- Payers’ Experiences Pre and Post Product Approval

    May 1, 2018, 00:00

  • Incorporating Reimbursement and Health Economics (RHE) into the New Product Development Process

    May 1, 2018, 00:00

  • A Systematic Review of Economic Outcomes Associated With Use of Topical Interventions for Treatment Of Chronic Wounds

    May 1, 2018, 00:00

  • A Systematic Review of Cost-Effectiveness Analysis Studies in Newborn Screening (NBS)

    May 1, 2018, 00:00

  • Prostate Cancer Costs In Colombia- A Top-Down Approach

    May 1, 2018, 00:00

  • An Economic Evaluation of a Familial Cancer Risk Management Program for Brca Mutation Carriers- An Australian Perspective

    May 1, 2018, 00:00

  • Efficacy and Safety of Fluticasone Furoate Nasal Spray for Perennial Allergic Rhinitis in Adults and Adolescents- A Systematic Review

    May 1, 2018, 00:00

  • Health Insurance Status and Outcomes Among Adults with Mycosis Fungoides in the United States

    May 1, 2018, 00:00

  • Analysis the Number of Cases of One-Day Surgical Patient Care in Hungarian University Clinical Centre’s Between 2010-2015

    May 1, 2018, 00:00

  • Cost-Effectiveness of Daclizumab Versus Interferon Beta-1A in the Treatment of Patients with Relapsing-Remitting Multiple Sclerosis in the United States

    May 1, 2018, 00:00

  • A Systematic Review of Discrete Choice Experiment and Conjoint Analysis in Measuring Patients’ Preferences for Multiple Sclerosis Treatments

    May 1, 2018, 00:00

  • Online Methods for the Electronic Validation of the Treatment Satisfaction for Medication Questionnaire

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Hepatitis C Treatments in Mexico- Genotype 2 and 3

    May 1, 2018, 00:00

  • Septic Revision of All Knee Components Following Total Knee Arthroplasty- Type and Payments for Care, and Incidence of 1-Year Re-Infection and Amputation

    May 1, 2018, 00:00

  • Cost-Effectiveness of Treating Romanian Post-Stroke Patients with Upper Limb Spasticity With Incobotulinumtoxin-A Against Conventional Therapy

    May 1, 2018, 00:00

  • Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada

    May 1, 2018, 00:00

  • Impact of Initiating Long-Acting Injectables on All-Cause and Psychiatric Hospitalization in Patients With Bipolar I Disorder

    May 1, 2018, 00:00

  • Utilizing Natural Language Processing and Machine Learning to Create a Better Member Experien Blue Cross Blue Shield of Louisiana (BCBSLA) Innovation in Action

    May 1, 2018, 00:00

  • The Humanistic Burden of Postpartum Depression- A Systematic Literature Review

    May 1, 2018, 00:00

  • Association Between Age at Initiation of Regular Cigarette Smoking and Age at Initiation Of Substance Use- A Cohort Study

    May 1, 2018, 00:00

  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Breast Cancer in Chinese Patients

    May 1, 2018, 00:00

  • Accountable and Reasonable Processes for Coverage Decision-Making for Rare Disease and Regenerative Therapies – Which Criteria Should be Considered and Why?

    May 1, 2018, 00:00

  • Conversion of Hypoglycemia Utility Decrements from Categorical Units Reflecting Event History into Event Specific Disutility Scores Applicable to Diabetes Decision Models

    May 1, 2018, 00:00

  • Personal Income Before and After Diagnosis of Multiple Sclerosis

    May 1, 2018, 00:00

  • A Retrospective Analysis of Tack Use With Progrip™ Laparoscopic Self-Fixating Mesh and 3dmax™ Mesh in Outpatient Hospital Inguinal Hernia Repair Procedures

    May 1, 2018, 00:00

  • A Case Management Approach to Reducing ER Visits- A Blue Cross Blue Shield of Louisiana (BCBLSA) Case Study

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Universal Vs Targeted Human Immunodeficiency Virus (HIV) Screening Approaches to Identify New HIV Diagnoses in the Emergency Department (ED)

    May 1, 2018, 00:00

  • Costs of Hodgkin and Non-Hodgkin Lymphoma in Fran Results on the Basis of the French National Health Insurance Database

    May 1, 2018, 00:00

  • Current Management of Specialty Drugs, Specialty Pharmacies and Biosimilar Drugs

    May 1, 2018, 00:00

  • Reimbursement of Vedolizumab According to the Indications- what are the Impacts in the 37 Public Hospitals of Paris?

    May 1, 2018, 00:00

  • Complete Economic Evaluation of the Use of Micronized Progesterone By Vaginal Administration for the Prevention of Preterm Birth in Pregnant Patients with Short Cervix in Mexico

    May 1, 2018, 00:00

  • The Effect of Medication Choice After Tumor Necrosis Factor Inhibitor (TNFI) use on the Healthcare Costs for Patients with Rheumatoid Arthritis- An Instrumental Variables Approach

    May 1, 2018, 00:00

  • The Long-Term Benefits of Ensuring Timely Treatment and Improved Medication Adherence in Early Schizophrenia- A Microsimulation Study

    May 1, 2018, 00:00

  • Recursively Imputed Survival Trees for Extrapolating Survival Beyond Clinical Trial Follow UP- A Simulation Study

    May 1, 2018, 00:00

  • Model-Based Network Meta-Analysis for Time Course Relationships- A Union of two Methodologies

    May 1, 2018, 00:00

  • Economic Burden of Non–Communicable Diseases (NCDS) In Poland

    May 1, 2018, 00:00

  • Review of Operative Outcomes of Robotic Surgical Procedures Performed with Robotic vs. Endoscopic Linear Staplers

    May 1, 2018, 00:00

  • Racial Trends in Non-Vitamin/Non-Mineral Medication Use During Pregnancy or Puerperium in the Ambulatory Care Setting

    May 1, 2018, 00:00

  • A Cost-Effectiveness Analysis of Voretigene Neparvovec for Vision Loss Due to Biallelic Rpe65-Mediated Inherited Retinal Disease

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Palbociclib for the Treatment of Patients with HR+/HER2− Advanced/Metastatic Breast Cancer in Bulgaria

    May 1, 2018, 00:00

  • Prevalence of Latent Tuberculosis Infection in Patients with Rheumatoid Arthritis in Colombia- A Single Setting Study

    May 1, 2018, 00:00

  • Psychometric Evaluation of the Psoriasis Symptoms Scale in Patients with Moderate to Severe Plaque Psoriasis

    May 1, 2018, 00:00

  • A Predictive Model to Identify Opioid-Induced Respiratory Depression Among Hospitalized Patients

    May 1, 2018, 00:00

  • A Work-Sampling Study of an Innovative Pediatric Care-Coordination Program for Asthma, Diabetes, and Sickle Cell Patients

    May 1, 2018, 00:00

  • Assessing Hospital Utilization of Patients Diagnosed with Marfan Syndrome

    May 1, 2018, 00:00

  • Patterns of Non-Adherence to Oral Antiviral Drugs

    May 1, 2018, 00:00

  • Relationship Between Early-Life Antibiotic Exposure and Childhood Obesity- A Systematic Review and Meta-Analysis

    May 1, 2018, 00:00

  • Self-Reported Insomnia Symptoms and Health Related Quality of Life in the US Adult Population

    May 1, 2018, 00:00

  • Economic Impact of Absenteeism and Deaths Due to Pneumonia in Brazilian Economy

    May 1, 2018, 00:00

  • Association Between Bleeding Events and Health-Related Quality-of-Life in Adults with Severe Hamophilia A

    May 1, 2018, 00:00

  • Cost-Effectiveness of Crizotinib for First-Line Treatment in Non-Small Cell Lung Cancer in Ecuador

    May 1, 2018, 00:00

  • Adaption and Validation of the Adherence Barriers Questionnaire for HIV Patients with Antiretroviral Therapy

    May 1, 2018, 00:00

  • How Will Payers Manage The High Cost Of Combinations Of New Oncology Agents, As Many Of These Therapies Become The Preferred Treatment Options To Optimize Patient Outcomes?

    May 1, 2018, 00:00

  • Cost-Effectiveness of Paliperidone Palmitate Long-Acting Injectable Versus Oral Antipsychotics For The Treatment Of Patients With Schizophrenia In Peru

    May 1, 2018, 00:00

  • Cabozantinib Versus Standard of Care in the first-Line Treatment of Advanced/Metastatic Renal Cell Carcinoma- A Network Meta-Analysis

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Primary Immunodeficiency- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Analytic Model to Estimate Costs of two Dialysis Modalities in Paraguay

    May 1, 2018, 00:00

  • Pharmacy Closures and Adherence to Cardiovascular Medications Among Older Adults in the U.S

    May 1, 2018, 00:00

  • A Retrospective Claims Analysis of Bronchodilator Monotherapy Versus Dual Bronchodilator Fixed-Dose Combination in Patients with COPD

    May 1, 2018, 00:00

  • Analysis of Success Rates for the Center for Medicare and Medicaid’s New Technology Add-On Payment Program

    May 1, 2018, 00:00

  • Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus- A Cost-Effectiveness Analysis in Canada

    May 1, 2018, 00:00

  • Hospitalisation Rate as a Proxy Outcome for Clinical Value in a Protocolised Cancer Treatment Environment

    May 1, 2018, 00:00

  • Quantifying the Added Societal Value of Public Health Interventions in Reducing Health Inequality

    May 1, 2018, 00:00

  • Modifiable Risk Factors and Population Attributable Risk of Obesity Among High School Students in the U.S

    May 1, 2018, 00:00

  • Factors Related to Non-Integrated or Fragmentation Polypharmacy in A Colombian Population

    May 1, 2018, 00:00

  • Impact of Skeletal-Related Events on Anti-Tumor Therapy Pattern in Patients with Bone Metastases from Prostate Cancer

    May 1, 2018, 00:00

  • US Payer Perspectives on Value and Comparisons Outside The US- An Interview Study

    May 1, 2018, 00:00

  • The Zero Dollar Copay Disease Management Program- Lowering Healthcare Utilization In Patients With Chronic Diseases

    May 1, 2018, 00:00

  • Trends in Regional Variation Among Inpatients with Breast Cancer in the United States- Analysis of 2010-2014 Healthcare Cost and Utilization Project Data

    May 1, 2018, 00:00

  • Does The Traditional Hta Process Appropriately Evaluate Brand+Brand Oncology Combination Drugs?

    May 1, 2018, 00:00

  • Study of Prevalence of Tobacco Use Among Children and Youth in India

    May 1, 2018, 00:00

  • The Professionals’ Perspective of Patient Involvement in Market Access- A Descriptive Analysis

    May 1, 2018, 00:00

  • Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access- Case of PCSK9 Inhibitors

    May 1, 2018, 00:00

  • The Growing Number Of High-Cost Advanced Therapy Medicinal Products (ATMPS) Pose Unprecedented Pricing And Funding Challenges To Current Models Of Healthcare

    May 1, 2018, 00:00

  • Association Between Insurance Type and Level of Care in Community-Living Patients with Alzheimer’s Disease and Related Dementias

    May 1, 2018, 00:00

  • A Critical Assessment Of The Role Of Health Outcomes Liaisons- Today And The Future

    May 1, 2018, 00:00

  • Geographic Variation of High-Risk Opioid Use and Risk of Overdose Among Disabled Medicare Beneficiaries in the US from 2011 to 2015

    May 1, 2018, 00:00

  • Systematic Literature Review (SLR) Of Health State Utility Values (HSUV) In Epidermal Growth Factor Receptor Mutant (Egfr-Mutant) Non-Small Cell Lung Cancer (NSCLC) Patients Previously Treated With Targeted Therapies

    May 1, 2018, 00:00

  • Number Needed to Treat in Patients with Spinal Muscular Atrophy Type 1 Treated with Avxs-101 Relative to Nusinersen

    May 1, 2018, 00:00

  • Heart Rate Variability Testing- Could it Change Spending for Rheumatoid Arthritis Patients in the United States? An Exploratory Economic Analysis

    May 1, 2018, 00:00

  • Real-World Data Analysis of Confirmatory Biopsy Utilization in Suspected Prostate Cancer Patients

    May 1, 2018, 00:00

  • Medication Synchronization Improves Medication Adherence

    May 1, 2018, 00:00

  • The Cost Effectiveness of Sealant Program Between Public and Private Hospital in Chiang Mai Thailand

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Rucaparib Maintenance Treatment for Recurrent Ovarian Carcinoma after Response to Platinum Therapy

    May 1, 2018, 00:00

  • Is Medication Adherence A Mediator of the Relationship Between Race/Ethnicity and Healthcare Cost in Patients with Rheumatoid Arthritis

    May 1, 2018, 00:00

  • Cost-Effectiveness of Therapeutic Drug Monitoring for Imatinib Administration in Patients with Chronic Myeloid Leukemia

    May 1, 2018, 00:00

  • Prevalence and Factors Associated with Uptake of the 3-Dose Catch-UP Primary Series of the Tetanus-Diphtheria Vaccine in a Recently Resettled Refugee Population

    May 1, 2018, 00:00

  • Role of Patient Assistance Program (PAP) in Market Access and Outcomes- Insights from Systematic Literature Review (2013-2017)

    May 1, 2018, 00:00

  • Characteristics of Patients Receiving Dmard Therapy for Rheumatoid Arthritis Management

    May 1, 2018, 00:00

  • Applying Population Health Management Techniques to Lower Healthcare Utilization in Patients with Non-Chronic Complex Diseases

    May 1, 2018, 00:00

  • Caregiver Burden Among Individuals Providing Informal Caregiving to Survivors of Major Adverse Cardiac Event (MACE)- A Systematic Review

    May 1, 2018, 00:00

  • Prescription Opioid Use Before and after An Overdose Event in Mississippi Medicaid

    May 1, 2018, 00:00

  • Healthcare Utilization of Metformin in Patients with Type 2 Diabetes and Either Congestive Heart Failure, Liver Impairment or Renal Impairment

    May 1, 2018, 00:00

  • Understanding Sepsis Recognition and Management in Emergency Room Settings to Improve Patient Outcomes

    May 1, 2018, 00:00

  • Trends in HTA Submissions for Rare Diseases- Insights from Review of Nice’s Highly Specialized Technology (HST) Assessment Reports

    May 1, 2018, 00:00

  • Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial

    May 1, 2018, 00:00

  • A Large-Scale Cross-Sectional Survey on Needle-Stick Injuries Related to Injections of Antidiabetics in China- Incidence and Infection Rates

    May 1, 2018, 00:00

  • Costs of Complications in Laparoscopic Bariatric Surgery

    May 1, 2018, 00:00

  • Reduction In Hospitalizations and Medical Cost Savings Associated with Early use of Adjunctive Atypical Antipsychotics in Major Depressive Disorder

    May 1, 2018, 00:00

  • Missing Data in Patient-Reported Outcomes- Regulatory, Statistical, and Operational Perspectives

    May 1, 2018, 00:00

  • Mothers’ Preferences and Willingness to Pay for Human Papillomavirus Vaccination for Their Daughters- A Discrete Choice Experiment in Hong Kong

    May 1, 2018, 00:00

  • The Budget Impact of Deflazacort for the Treatment of Duchenne Muscular Dystrophy (DMD)

    May 1, 2018, 00:00

  • A Standardized Cognitive Interview Approach to Ensure Quality in Caregiver-Recorded Videos of Duchenne Muscular Dystrophy Patients’ Physical Function for Clinical Evaluation

    May 1, 2018, 00:00

  • Quantifying the Importance of Model Parameters and Structural Assumptions on the Value of Treatments for Rheumatoid Arthritis Using Metamodeling

    May 1, 2018, 00:00

  • Systematic Review and Network Meta-Analysis of Approved Medicines for the Treatment of Idiopathic Pulmonary Fibrosis

    May 1, 2018, 00:00

  • Long-Term Effectiveness of a Gambling Intervention Program Among Children in Central Illinois

    May 1, 2018, 00:00

  • Association Between Sodium-Glucose Cotransporter-2 (SGLT-2) Inhibitors and Lower Extremity Amputation- A Retrospective Cohort Study

    May 1, 2018, 00:00

  • Aligned Strategies Identified by Prescribers and Managed Care to Close Treatment Decision Gaps in HCV and HIV

    May 1, 2018, 00:00

  • Older Patients’ Perception to Deprescribing In Resource Limited Settings- A Cross Sectional Study in an Ethiopia University Hospital

    May 1, 2018, 00:00

  • Extending Inferences from Randomized Participants to All Eligible Individuals Using Clinical Trials Nested Within Cohorts

    May 1, 2018, 00:00

  • Trends in Hospitalization Lenght of Stay and Costs in Patients with Hepatocellular Carcinoma (HCC)- Analysis of US National In-Patient Data for 2015

    May 1, 2018, 00:00

  • Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function

    May 1, 2018, 00:00

  • Natural Language Processing Methods Enhance Mace Identification from Electronic Health Records

    May 1, 2018, 00:00

  • Do Words Matter? Patient Perspetives on Conceptually Similar Symptoms and Impacts Frequently Utilized in Patient-Reported Outcome (PRO) Measures

    May 1, 2018, 00:00

  • Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1- A Canadian Cost-Utility Analysis

    May 1, 2018, 00:00

  • Hospital Lenght of Stay and Costs In Patients with Urinary Track Infections- Analysis of US National In-Patient Data for 2015 Using ICD-9 and ICD-10 Diagnoses

    May 1, 2018, 00:00

  • An Observational Study of Ivacaftor in Patients with Cystic Fibrosis and Selected Non-G551D Gating Mutations in UK, Italy and Netherlands- Healthcare Resource Utilization from the First Interim Analysis of the Vocal Study

    May 1, 2018, 00:00

  • Projecting survival with cure mixture models- when are the data mature enough for reliable analysis?

    May 1, 2018, 00:00

  • Core Outcome Sets in Clinical Research- What are They and How Can they Help Decision Makers?

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions in Malaysia

    May 1, 2018, 00:00

  • Economic Impact of French Public Regulations on Ferric Carboxymaltose in 39 Paris Public Hospitals Over the 2013-2016 Period

    May 1, 2018, 00:00

  • Vost Effectiveness of Blinatumomab Vs Inotuzomab Ozogamicin (INOTUZUMAB) in Adult Patients with Relapsed or Refracory (R/R) Acute Lymphoblastic Leukemia (ALL) with Zero or One Prior Salvage Therapy (S0/S1) from a US Payer Perspective

    May 1, 2018, 00:00

  • The Economic Burden of Skin Symptoms in Psoriatic Arthritis

    May 1, 2018, 00:00

  • Racial/Ethnic Disparity in HRQoL- Implications of Social Support and Social Connectedness in Thyroid Cancer Care

    May 1, 2018, 00:00

  • Evaluation of Potentially Inappropriate Medications and Clinical Outcomes in Older Adults Admitted to the Medical Intensive Care Unit

    May 1, 2018, 00:00

  • Analysis of Health Insurance Coverage by Citizenship Status in the United States

    May 1, 2018, 00:00

  • An Analysis of the Applications for Confirmation on Whether to Belong to the Subjects of the New Health Technologies Assessment in Korea

    May 1, 2018, 00:00

  • Cost Analysis Of Lipid Goal Attainments And Their Relationship With Clinical Outcomes In Chinese Post-Percutaneous Coronary Intervention Acute Coronary Syndrome Patients

    May 1, 2018, 00:00

  • Geographic Variation in Utilization of Physician Services Among Older Adults Diagnosed with Non-Hodgkin Lymphoma

    May 1, 2018, 00:00

  • Nutritional Situation in Under – 5 in “Montes De Maria”, Post-Conflict Zone in Colombia- 2017

    May 1, 2018, 00:00

  • Biosimilars- Barriers and Opportunities to Market Access in the United States

    May 1, 2018, 00:00

  • Predictive Model for Earlier Diagnosis of Dementia Using Administrative Claims

    May 1, 2018, 00:00

  • A Prospective Clinical Observational Study on Assessment of Risk Factors, Diagnosis and Prescribing Patterns of Medications for Migraine

    May 1, 2018, 00:00

  • A Comparison Of Patient And Caregiver Worries For Acute Myeloid Leukemia

    May 1, 2018, 00:00

  • Impact of Distal Radius Sterile KIT on Provider Budget in the USA

    May 1, 2018, 00:00

  • Medical Resource Utilization and Expenditures in Texas Medicaid Patients Taking Deferasirox Dispersible Tablets and Those Taking Deferasirox Film-Coated Tablets

    May 1, 2018, 00:00

  • Impact of the Hitech Act’s Incentive Program on the Adoption of Drug-Drug Interaction Alerts and Electronic Prescribing in the Ambulatory Care Setting

    May 1, 2018, 00:00

  • Cost-Effectiveness of Ceftolozane/Tazobactam as Empiric Therapy for the Treatment of Complicated Urinary Tract Infections in Colombia

    May 1, 2018, 00:00

  • Free-Flap Mandibular Reconstructions- Patient Demographics And Resource Utilization in the United States

    May 1, 2018, 00:00

  • Effect of Depression on Adherence to Controller Medications and Healthcare Resource Utilization in Asthma Patients

    May 1, 2018, 00:00

  • Cost-Effectiveness of Niraparib Versus Routine Surveillance and Olaparib for the Maintenance Treatment of Adult Patients with Ovarian Cancer in the United States

    May 1, 2018, 00:00

  • Is the Orphan Drug Act Being used as a Loophole to Extend Periods of Drug Exclusivity?

    May 1, 2018, 00:00

  • Barbec(EU)D Oncology Market Access – Part D(EU)X

    May 1, 2018, 00:00

  • Direct Costs Associated with Multiple Myeloma Model Patient in 2017 From Single EU Jurisdiction

    May 1, 2018, 00:00

  • Symptoms And Impacts In Advanced/Metastatic Gastric Or Gastroesophageal Junction Cancer- Findings From Qualitative Patient Interviews

    May 1, 2018, 00:00

  • Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

    May 1, 2018, 00:00

  • Accepting Biosimilars - what are the Doctors Looking for? - A Systematic Review

    May 1, 2018, 00:00

  • Patient Access to Medicines for Rare Diseases in European Countries

    May 1, 2018, 00:00

  • Shared Decision-Making in Children and Adolescents with Mental Health Conditions

    May 1, 2018, 00:00

  • Self-Reported Experiences of Gender, Race, And Immigration Related Discrimination in Health Economics, Outcomes Research, And Market Access Professions

    May 1, 2018, 00:00

  • Cost-Effectiveness of Short-Course Radiotherapy Compared to Long-Course Chemoradiotherapy in the Treatment of Stage Iii Rectal Cancer Patients from the US Societal Perspective

    May 1, 2018, 00:00

  • Cost Analysis of Medication Therapy Management - Using Propensity Score Matching Method

    May 1, 2018, 00:00

  • Asthma-COPD Overlapping as a Risk Factor for Healthcare Utilizations Among Adults with Asthma

    May 1, 2018, 00:00

  • Inpatient Cost and Complications of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Hodgkin’s Lymphoma (NHL)

    May 1, 2018, 00:00

  • An International Comparison of Antineoplastic and Imunomodulating Agent Price in Thirteen Countries - Patented Medicines, Chemical Entities, and Biologics

    May 1, 2018, 00:00

  • Reasons for Non-Adherence with Statins Among Patients Who Had a Primary Cardiovascular Disease Event

    May 1, 2018, 00:00

  • The Relationship Between Medical Insurance Coverage and Medication Payments in The US from 1997 to 2015

    May 1, 2018, 00:00

  • Availability of Pharmacies Participating in the 340B Drug Pricing Program, 2016

    May 1, 2018, 00:00

  • A Hospital Budget Impact Model to Estimate the Impact Associated with Phasix™ and Phasix™ St Mesh Versus Stratticetm Matrix in Complex Ventral Hernia Repair Procedures

    May 1, 2018, 00:00

  • Assessing the Economic Burden and 30-Day Readmission Rates Among Patients with Chronic Obstructive Pulmonary Disease in the US Veterans Health Administration Population

    May 1, 2018, 00:00

  • Analysis of Minimization of Costs of Equivalent Therapeutic Alternatives (ATE) in a General Hospital of Belo Horizonte / Mg, Brazil

    May 1, 2018, 00:00

  • Economic Value of Genetic Testing for Cancer Drugs with Clinically Relevant Drug-Gene Associations- A Systematic Literature Review

    May 1, 2018, 00:00

  • Attitudes and Beliefs Towards Psychotropic Medication in Patients with Dual Diagnosis

    May 1, 2018, 00:00

  • Prescription Drugs Prices and Source of Payments in The US from 1997 to 2015

    May 1, 2018, 00:00

  • Implementation of Piecewise Structural Equation Modelling (SEM) as an Alternative to Traditional Sem- A Simulation Study

    May 1, 2018, 00:00

  • Patient-Reported Outcome Use And Completion Information In Non-Randomized Cancer Trials

    May 1, 2018, 00:00

  • Discontinuation, Switching and Restarting Among Migraine Patients Initiating Prophylaxis

    May 1, 2018, 00:00

  • Efficacy and Inhibitor Development of Prophylactic vs On-Demand Factor VIII and IX in the Management of Haemophilia Patients from Southeast Asia- A Systematic Review

    May 1, 2018, 00:00

  • Analysis of Performance to Maximise Effectiveness of Resource Allocation in an Integrated Care Team Plan

    May 1, 2018, 00:00

  • Health-Related Quality of Life Assessments Predict Relapse or Death in Patients with Newly Diagnosed Multiple Myeloma (MM)- Results from the Connect® MM Registry

    May 1, 2018, 00:00

  • Accounting for Known Unknowns in the American College Of Medical Genetics (ACMG) Recommendations for NBS- Policy Implications of Accounting for Uncertainty in Assessment in the Case of Medium Chain Ketoacyl-COA Thiolase Deficiency (MCKAT) N ...

    May 1, 2018, 00:00

  • Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer- A Medical Record Review Study In The United States And Canada

    May 1, 2018, 00:00

  • Evaluation Of Meaningful Change In Patient-Related Outcomes For Patients With Cutaneous T-Cell Lymphoma

    May 1, 2018, 00:00

  • Real-World Infection and Non-Union Rates Associated With Closed or Open Fractures of the Tibial Shaft Requiring Open Reduction and Internal Fixation

    May 1, 2018, 00:00

  • An Economic Evaluation of Market Forces on Orphan Drug Research Following Changes in American Tax Law

    May 1, 2018, 00:00

  • The Cost of Drugs for Age-Related Macular Degeneration in Canada and Internationally

    May 1, 2018, 00:00

  • Patient Definitions of Improvement- Most Frequent Reasons for Defining Disease Improvement as Reported by Patients with Diabetes, Chronic Obstructive Pulmonary Disease (COPD), Depression or Osteoarthritis (OA)

    May 1, 2018, 00:00

  • Does the Timing of a Drug’s Costs and Benefits Influence us Payer Coverage of Special Drugs?

    May 1, 2018, 00:00

  • Adherence Issues in Fibromyalgia- How Can Acceptance Measurement Help Understanding Patients' Concerns and Working on Solutions?

    May 1, 2018, 00:00

  • Antecedents of Patient Participation in Prescription Medication Decision

    May 1, 2018, 00:00

  • Identifying Cancer Trials That Incorporate Patient-Reported Outcome Measures- Comparing Fda Study Reports To Clinicaltrials.Gov

    May 1, 2018, 00:00

  • Impact of Medical Marijuana Legalization on Opioid use, Chronic Opioid use and High-Risk Opioid use

    May 1, 2018, 00:00

  • Systematic Review of Poly (ADP-RIBOSE) Polymerase Inhibitors for Treatment of Ovarian Cancer

    May 1, 2018, 00:00

  • Comparing Literature Review Requirements for Reimbursement Submissions Across the Globe

    May 1, 2018, 00:00

  • Annual Change in Controlled Substance Opioid Prescribing and Concomitant Medications from an Urban Academic Emergency Department from 2011 – 2016

    May 1, 2018, 00:00

  • Impact of Human Papillomavirus (HPV) Etiology and Immuno-Oncology Therapy (IO) Availability on the Patient Journey In Squamous Cell Carcinoma of the Head and Neck (SCCHN)

    May 1, 2018, 00:00

  • Treatment Patterns, Healthcare Resource Utilization And Associated Costs By Line Of Therapy In Newly Diagnosed Merkel Cell Cancer Patients In The United States

    May 1, 2018, 00:00

  • Comparative Effectiveness Of Apixaban Versus Warfarin For The Prevention Of Recurrent Venous Thromboembolism And Cardiovascular Diseases In Patients With Venous Thromboembolism

    May 1, 2018, 00:00

  • Comparison of Economic and Clinical Outcomes Between Skin Staples Plus Wound Dressings and 2-Octyl Cyanoacrylate Plus Polymer Mesh Tape Among Patients Undergoing Cesarean Section

    May 1, 2018, 00:00

  • Incremental Effect of Quality Blue Practices on Disease Management in Louisiana

    May 1, 2018, 00:00

  • Bridging the Consumerization of Healthcare into the Laboratory Test Setting

    May 1, 2018, 00:00

  • The Incremental Cost of Post-Surgical Complications Following Breast Surgery

    May 1, 2018, 00:00

  • Incidence of Reoperations after Laparoscopic Bariatric Surgery

    May 1, 2018, 00:00

  • Rapid Dissemination of H. Pylori Eradication for Chronic Gastritis Among Asymptomatic People

    May 1, 2018, 00:00

  • Burden Of Disease Of Acute Myocardial Infarction In Hungary

    May 1, 2018, 00:00

  • Cost-Effectiveness of Sarilumab Versus Adalimumab for Treating Patients with Active Rheumatoid Arthritis- A Markov Model Assessment

    May 1, 2018, 00:00

  • The Cost-Effectiveness of Ustekinumab Compared to Infliximab And Adalimumab in Adult Patients with Moderate-Severe Crohn's Disease (Tnf Naïve Population)

    May 1, 2018, 00:00

  • Benchmarking HIV Quality Measures in the US Opera HIV Cohort

    May 1, 2018, 00:00

  • 2018 Update Of Health Technology Assessment Decisions Across The Globe- A Focus On Oncology

    May 1, 2018, 00:00

  • The Effectiveness of Integrated Treatment of Generalized Periodontitis for Patients with Chronic Hepatitis C

    May 1, 2018, 00:00

  • The Impact of Post-Diagnosis Depression on Survival and Healthcare Costs for Patients Diagnosed with Late-Stage Cancer in the United States

    May 1, 2018, 00:00

  • Using Private Claims Data to Study the Cost of the Opioid Crisis

    May 1, 2018, 00:00

  • Machine Learning to Detect and Diagnose Atrial Fibrillation and Atrial Flutter (AF/F) Using Routine Clinical Data

    May 1, 2018, 00:00

  • Economic Value of Precision Medicine- An Example of Asthma

    May 1, 2018, 00:00

  • The Impact of a Value-Based Insurance Design for Chronic Preventive Medications on Adherence and Persistence in an Integrated Delivery System

    May 1, 2018, 00:00

  • Matching-Adjusted Indirect Comparisons (MAICS) of Efficacy and Consumption of Bay 94-9027 Versus three Recombinant Factor VIII (RFVIII) for Prophylaxis of Severe Hemophilia A

    May 1, 2018, 00:00

  • Costs of Hepatitis C- How Much Does it Cost Not to Treat a Patient with Hepatitis C

    May 1, 2018, 00:00

  • Burden of Genital Warts in Colombia- An Observational Study

    May 1, 2018, 00:00

  • Rare Diseases- Addressing the Challenges in Diagnosis, Drug Approval, and Patient Access

    May 1, 2018, 00:00

  • Use Of Real-World Evidence In Clinical Decision Making By Community Oncologists

    May 1, 2018, 00:00

  • Economic Evaluation of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma

    May 1, 2018, 00:00

  • Navigating Real World Evidence in Oncology – Where to Go and Why

    May 1, 2018, 00:00

  • A Cost Effectiveness Analysis (CEA) of Phenytoin (PHT) Versus Levetiracetam (LEV) for Early Seizure Pharmacoprophylaxis after Traumatic Brain Injury (TBI) from A US Institutional Perspective- An Upgrade of a Cost Minimization Analysis (CMA) ...

    May 1, 2018, 00:00

  • Mandatory Meningococcal Serogroup B Vaccination for College Students is Not Cost-Effective

    May 1, 2018, 00:00

  • Cost-Effectiveness of Regular Utilization of Zoledronic Acid for Developed Bone Metastases from Advanced Lung Cancer in Chinese Patients

    May 1, 2018, 00:00

  • Regional Variations in the Prevalence of Opioid use Disorders, Treatment Among Pregnant Women, And Newborns with Adverse Outcomes in a Commercially Insured Pregnant Population

    May 1, 2018, 00:00

  • Incidence of Malignant Neoplasm for Patients Using Biologic Drugs- A Nested Case-Control Study Using Medicare 5% Sample Datasets

    May 1, 2018, 00:00

  • Systematic Review of the Direct Cost of Lung Cancer in China

    May 1, 2018, 00:00

  • Health Economic Model for Estimating the Direct Cost Impact of Adopting a Vascular Access Antimicrobial Bundle of Solutions in ICU Settings in Germany

    May 1, 2018, 00:00

  • Modeling the Impact on Clinical Utility, Patient Harms, And Cost of Biomarkers for the Management of Incidentally Detected Pulmonary Nodules

    May 1, 2018, 00:00
  • «
  • 61
  • 62 (current)
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • »